Meisys Revenue and Competitors

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Meisys's estimated annual revenue is currently $21.3M per year.(i)
  • Meisys's estimated revenue per employee is $201,000

Employee Data

  • Meisys has 106 Employees.(i)
  • Meisys grew their employee count by 3% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$21.3M1063%N/AN/A
Add Company

What Is Meisys?

Meisys is a Medical Information, Drug Safety, Regulatory and Medical Affairs outsourcing company providing medical, scientific and technical services to the pharmaceutical industry. We specialize in Drug Safety and Regulatory consultancy services, Medical Information managing call centers for Patient Support Programs, DAP and Health Care Professionals (product enquiry). Highest quality Medical Affairs support in medical writing, expert medical advise on product development / marketing and Continued Medical Education. System solutions / database for Medical Information Departments and Drug Safety AE recording and reporting. Specialties Call Center for patients and HCP. Patient Support Programs Call Centers (tretament adherence, cumplimiento terapéutico) Disease Awareness Programs (Programs de Educación a pacientes). DTC Direct to Consumer Medical Communications. Programas de Apoyo a Pacientes. Proprietary Medical Information and Drug Safety Recording, Tracking and Reporting Systems (Base de datos para registro de consutas de Información Médica y AEs) * Call Center for patients, citizens and HCP * Patient Support Programs -treatment adherence * DTC Direct to Consumer Medical Communications * Medical Affairs support, Medical advisors * Continued Medical Education * Drug safety outsourcing. PV tracking & reporting system

keywords:N/A

N/A

Total Funding

106

Number of Employees

$21.3M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30.7M1063%N/A
#2
$3.5M10610%N/A
#3
$24.3M10741%N/A
#4
$15.5M107-1%N/A
#5
N/A1079%N/A